Latest Partner Content

51% of Americans 50-54 have not been screened for colorectal cancer. We know screening saves lives, here's why.

Stupid Cancer is excited to bring CancerCon® to Seattle, WA this April 16 - 19, 2020. 

Sexual and gender minorities are not receiving the same standard of clinical care as other patients with cancer.

This article outlines three areas where LGBTQ patients and their caregivers may face challenges and how the Comprehensive Cancer Control Programs (CCCP) can address these needs. Written by Dr. Amari Pearson- Fields, the former Comprehensive Cancer Program Director for Washington DC.

Lisa Schlager, vice president of public policy at FORCE: Facing Our Risk Empowered, sits down with CURE® to discuss genetic mutations in men that are not being addressed.

Lisa Schlager, vice president of public policy at FORCE: Facing Our Risk Empowered, discussed the various laws and legislation put into place to protect those who have a genetic predisposition to cancer.

Lisa Schlager, vice president of public policy at FORCE: Facing Our Risk Empowered, offered background on the differences between genetic testing and a direct-to-consumer test, and why patients should be careful when using over-the counter genetic tests.

Lee Greenberger, chief scientific officer at the Leukemia and Lymphoma Society, discusses the use of immunotherapy in blood cancer treatment.

Lee Greenberger, chief scientific officer at the Leukemia and Lymphoma Society, discusses treatment advances in the multiple myeloma space.

HPV and Anal cancer are associated with one another, here's what you need to know.